Clinical Trials Logo

Femur Head Necrosis clinical trials

View clinical trials related to Femur Head Necrosis.

Filter by:

NCT ID: NCT02799654 Withdrawn - Hip Fractures Clinical Trials

Excia T Cementless EBRA Study

Start date: August 2017
Phase: N/A
Study type: Observational

In this Post Market Clinical Follow-up Study (PMCF Study), the short-term clinical and radiological results of the cementless Excia T® prosthesis in routine clinical use shall be assessed and the migration taking place in the first 24 months evaluated.

NCT ID: NCT02735538 Completed - Clinical trials for Osteonecrosis of Femoral Head

Transcription Factor Runx2 in Necrotic Femoral Head Tissue

Start date: July 2009
Phase: N/A
Study type: Observational

The trial detected mRNA expression of several bone repair-related genes, including Runx2, in the femoral head and neck of patients with osteonecrosis of femoral head (ONFH) . Runx2 expression was compared with that of identical tissue from osteoarthritis patients to identify expression in necrotic femoral head tissue, which will help clarify the role and possible clinical significance of Runx2 in femoral head necrosis, bone repair and reconstruction.

NCT ID: NCT02733900 Completed - Femur Head Necrosis Clinical Trials

Modifications of the Subchondral Bone in Aseptic Osteonecrosis of the Femoral Head

ONTF
Start date: February 2016
Phase: N/A
Study type: Interventional

In this study, the aim is to identify the modifications responsible for aseptic osteonecrosis of the femoral head and its structural evolution by the association of the micro scanner analysis and Raman spectrometry performed on the femoral heads removed during hip replacements. The study of femoral heads will allow the analysis of bone tissue at two different scales, both correlated with the biomechanical properties of the bone. Also, the association with preliminary MRI analysis will provide pathogenic explanations correlated to these modifications.

NCT ID: NCT02655120 Terminated - Clinical trials for Aseptic Necrosis of Femur Head

Autologous Bone Marrow and BMP7 Treatment in the Necrosis in the Femoral Head of the Adult

BMP7
Start date: March 2005
Phase: N/A
Study type: Interventional

The main objective of the study is to evaluate the effectiveness of the injection of bone marrow unconcentrated more R BMP 7 to repair necrosis of the femoral head with stage I-III classification FICAT.

NCT ID: NCT02633904 Not yet recruiting - Femur Head Necrosis Clinical Trials

Investigation of the Femoral Shortening Osteotomy in the Developmental Dislocation of the Hip (FSODDH)

FSODDH
Start date: December 2015
Phase: N/A
Study type: Interventional

Although older children and high dislocations may be more likely to require a femoral shortening osteotomy, the ultimate decision about whether or not to shorten a given femur should depend on the ease of femoral head reduction in that specific patient. Adding a femoral shortening procedure increases operating time and blood loss, adds a second incision, and necessitates future hardware removal. In addition, an unnecessary femoral shortening osteotomy could overly decrease the soft tissue tension around the joint, putting the hip at risk for redislocation. This study was designed to explore an algorithm based on strict age and radiographic criteria that identify those without the need of femoral osteotomy.

NCT ID: NCT02552069 Recruiting - Clinical trials for Rheumatoid Arthritis

Tritanium® Study in Japan

Start date: June 2015
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to evaluate early fixation and stability of the Tritanium cup. It is expected that the Tritanium® cup will be equal to or better than conventional cementless cups in early fixation/stability and meet the expectations of Japanese surgeons.

NCT ID: NCT02379663 Completed - Osteoarthritis, Hip Clinical Trials

Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty

Start date: January 2012
Phase: Phase 4
Study type: Interventional

This prospective study compares an oral direct factor Xa inhibitor with LMWH for thromboprophylaxis in the patients undergoing THA.

NCT ID: NCT02365077 Enrolling by invitation - Femur Head Necrosis Clinical Trials

GWAS Identified Susceptibility Loci for Glucocorticoid-induced FHN in the Chinese Population

Start date: January 1, 2015
Phase:
Study type: Observational [Patient Registry]

This is a observation clinical trial. We are collecting the patients with glucocorticoid. They were divided into the experiment group (with femur head necrosis) and control group (without femur head necrosis).Then, we will analyse the patients' genome with genome-wide association study (GWAS). Our purpose is to find susceptibility loci for glucocorticoid-induced femur head necrosis in the Chinese population.

NCT ID: NCT02338596 Completed - Coxarthrosis Clinical Trials

Ultra-Short Anatomic and Conventional Cementless Stems Cementless Stems in Patients Younger Than Fifty-Five Years Old

Start date: June 2001
Phase: Phase 4
Study type: Interventional

As clinical and radiographic performance of an ultra-short anatomic cementless stem have been investigated only two randomized controlled studies, well-designed trials should aim for a thorough comparison of the outcomes of ultra-short and conventional cementless stems. The purpose of this study was to compare the outcomes of ultra-short and conventional stems in the same young patients who underwent simultaneous bilateral sequential total hip arthroplasties.

NCT ID: NCT02288117 Active, not recruiting - Osteoarthritis, Hip Clinical Trials

Prospective Clinical 5-year Follow-up of the LINK® SP-CL® Hip Prosthesis Stem

Start date: July 2015
Phase:
Study type: Observational

The objective of this PMCF is to collect clinical and radiographic outcome information on Total Hip Arthroplasty (THA) performed with LINK® SP-CL® Hip Prosthesis Stem under routine conditions. The results collected will be used to clinically confirm the performance and safety of the LINK® SP-CL® Hip Prosthesis Stem in terms of the manufacturer's obligation to perform a PMCF. Furthermore the results can be used for future regulatory processes if needed.